Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

The Hidden Dangers of Meftal: A Drug Safety Alert for a Frequently Used NSAID

Author(s): Priyanka Paul, Raj Kamal and Rohit Bhatia*

Volume 30, Issue 25, 2024

Published on: 19 June, 2024

Page: [1949 - 1951] Pages: 3

DOI: 10.2174/0113816128304156240606050525

Price: $65

Next »
[1]
Central drugs standard control organization. Available from: https://cdsco.gov.in/opencms/opencms/en/Home
[2]
Ahmad A, Patel I, Sanyal S, Balkrishnan R, Mohanta GP. A study on drug safety monitoring program in India. Indian J Pharm Sci 2014; 76(5): 379-86.
[PMID: 25425751]
[3]
Vaishnavi SG, Sachin H, Priyanka DY, Mohini AG, Ayesha NS, Madhav H. A review on banned drugs. AJPRD 2023; 11(6): 31-5.
[http://dx.doi.org/10.22270/ajprd.v11i6.1331]
[4]
Govt bans 14 fixed dose combination drugs including Nimesulide and Paracetamol, citing health risk; check full list here. Available from: https://www.livemint.com/news/govt-bans-14-fixed-dose-combination-drugs-including-paracetamol-citing-health-risk-full-list-here-11685840967218.html
[5]
Meftal advisory: Why has government issued a safety alert against painkiller? Available from: https://www.indiatoday.in/health/story/why-has-the-government-issued-a-safety-alert-against-painkiller-meftal-2473604-2023-12-08
[6]
Government advisory alerts users about Meftal's risks: Here's everything you need to know about it. Available from: https://economictimes.indiatimes.com/news/new-updates/government-advisory-alerts-users-about-meftals-risks-heres-everything-you-need-to-know-about-it/articleshow/105857731.cms
[7]
Weiss D, Kinaciyan T. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by mefenamic acid. JAAD Case Rep 2019; 5(1): 89-90.
[http://dx.doi.org/10.1016/j.jdcr.2018.10.015] [PMID: 30581942]
[8]
Doğan NÖ, Çaylak ST, Yılmaz S. Central nervous system toxicity due to mefenamic acid. Am J Emerg Med 2019; 37(3): 561.
[http://dx.doi.org/10.1016/j.ajem.2018.11.027] [PMID: 30470601]
[9]
Wurm S, Schreiber F, Spindelboeck W. Mefenamic acid: A possible cause of drug-induced acute pancreatitis. Pancreatology 2015; 15(5): 570-2.
[http://dx.doi.org/10.1016/j.pan.2015.08.003]
[10]
De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: An update and review of recent literature. Indian J Dermatol 2018; 63(1): 30-40.
[http://dx.doi.org/10.4103/ijd.IJD_582_17] [PMID: 29527023]
[11]
Blue Cross responds to IPC alert on mefenamic acid in meftal brands. Available from: https://www.thehindubusinessline.com/companies/blue-cross-responds-to-ipc-alert-on-mefenamic-acid-in-meftal-brands/article67628317.ece

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy